Nasdaq Nordic: Nasdaq Stockholm Welcomes Redwood Pharma to the Nasdaq First North Growth Market
Stockholm, April 14, 2021 - Nasdaq (Nasdaq: NDAQ) announces that trading in
Redwood Pharma AB s shares (short name REDW) commences today on Nasdaq First
North Growth Market. The company belongs to the Health Care sector. Redwook
Pharma is the 34rd company to be admitted to trading on Nasdaq s Nordic
markets in 2021.
Redwood Pharma is a health care company, developing ophthalmic drugs in areas
where medical need is especially great. The company s approach is exemplified
by their very first project, RP101. RP101 treats chronic dry eyes in
post-menopausal women. Something that is possible thanks to their drug delivery
Nasdaq Nordic: Nasdaq Stockholm Welcomes Plexian to the Nasdaq First North Growth Market
Stockholm, April 14, 2021 - Nasdaq (Nasdaq: NDAQ) announces that trading in
Plexian AB s shares (short name PLEX) commences today on Nasdaq First North
Growth Market. The company belongs to the Technology sector. Plexian is the
35th company to be admitted to trading on Nasdaq s Nordic markets in 2021.
Plexian is a technology company that provides an innovative payment solution.
With their product Plexian Edge, the company enables businesses to offer a
richer experience to their customers, hence challenging traditional payment
solutions. With the Plexian mobile wallet, the mobility of an app is combined
Nasdaq Stockholm AB: Tre Kronor Property Investment AB receives observation status (153/21)
Today, April 13, 2021,LSTH Svenska Handelsfastigheter AB disclosed a public
takeover offer to the shareholders in Tre Kronor Property Investment AB.
The rules of Nasdaq First North Growth Market state that a listed company may
be given observation status if the company is subject to a public takeover
offer.
With reference to the above, Nasdaq Stockholm AB decides that the shares in Tre
Kronor Property Investment AB (3KR, ISIN code SE0010169516, order book ID
145914) shall be given observation status.
For further information about this exchange notice please contact Issuer
Surveillance, telephone +46 8 405 60 00.
Waters Corporation: Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization
NEWS SUMMARY:
Collaboration intended to bring speed and simplicity to bio-characterization workflows
Automated workflows to cut the time and effort required to monitor critical quality attributes of biotherapeutics in regulated laboratories
Waters and Genovis share goal of advancing the science behind the analysis of glycoproteins and protein therapeutics
Waters Corporation (NYSE:WAT) and Genovis AB (Nasdaq First North Growth Market) are formally collaborating to develop and market complete routine biopharmaceutical characterization workflows based on the Waters BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. The goal of the collaboration is to develop automated workflows for the rapid and consistent characterization of critical quality attributes (CQAs) of monoclonal antibodies (mAbs) and other protein-based drugs in bioprocess de
Nasdaq Stockholm AB: The observation status for Online Brands Nordic AB is updated (152/21)
On March 10, 2020, the shares in Online Brands Nordic AB (the Company ) were
given observation status with reference to the Company s decision to apply for
company reconstruction.
On July 31, 2020, the observation status was updated after an annual general
meeting of shareholders in the Company had elected only two members to its
board of directors.
On February 12, 2021, the Company issued a press release with information that
the reconstruction of the Company had been completed.
On February 18, 2021, the Company issued a press release with information that
a new member had been elected to the Company s board of directors, thereby